• Home
• Responsibility
• CR Report 2004
• Leadership and advocacy
• Science policy conferences

Science policy conferences

GSK R&D is sponsoring a series of annual science policy conferences in the UK on issues relating to the conduct of pharmaceutical and biomedical research. The aim is to promote discussion and dialogue between key stakeholders including policy makers, regulators, pharmaceutical companies, scientists, doctors and patient groups.

The first conference took place in 2003 and was organised in conjunction with the Department of Health and the National Institute for Clinical Excellence. It focused on how medicines are evaluated by regulators, pharmaceutical companies, patients and other stakeholders and looked at how the current system could be improved to address medical needs more effectively. It highlighted a potentially important role for the NHS as a source of research data for evaluating medicines in clinical practice.

In 2004 the conference was organised with the Department of Health and the Academy of Medical Sciences. It looked at issues influencing the quality of clinical research in the UK including the regulatory framework, funding mechanisms, the provision of infrastructure and the importance of adequate career development and training provisions. It highlighted actions needed to improve clinical research for the benefit of patients, for example, the need to increase patient involvement by putting more information on clinical research into the public domain.

Back to top